Open access
2,951
Views
2
CrossRef citations to date
0
Altmetric
Rheumatology
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab
Iris Lina Janssen Scientific Affairs, LLC, Horsham, PA, USA
https://orcid.org/0000-0003-0176-4435
Richard Melsheimerb Janssen Biologics BV, Leiden, the Netherlands
https://orcid.org/0000-0002-8378-5186
Rachel H. Bhakc Analysis Group, Inc, Boston, Massachusetts, USA
, Patrick Lefebvred Analysis Group, Inc, Montréal, Québec, Canada
, Maral DerSarkissiane Analysis Group, Inc, Los Angeles, California, USA
, Bruno Emondd Analysis Group, Inc, Montréal, Québec, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-0060-765X
Angela Laxc Analysis Group, Inc, Boston, Massachusetts, USA
, Catherine Nguyene Analysis Group, Inc, Los Angeles, California, USA
, Melody Wuc Analysis Group, Inc, Boston, Massachusetts, USA
https://orcid.org/0000-0002-7928-0126
Yinong Young-Xuf White River Junction VA Medical Center, White River Junction, VT, USA
show all
Pages 613-627
|
Received 29 Sep 2021, Accepted 01 Feb 2022, Published online: 18 Feb 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.